Triage of high-risk HPV positive women in cervical cancer screening.

作者: Renée MF Ebisch , Albert G Siebers , Remko P Bosgraaf , Leon FAG Massuger , Ruud LM Bekkers

DOI: 10.1080/14737140.2016.1232166

关键词:

摘要: ABSTRACTIntroduction: High-risk human papillomavirus (hrHPV) testing is expected to replace cytology as primary screening method for cervical cancer in an increasing number of countries. The high sensitivity hrHPV combined with a limited specificity which makes triaging positive women necessary. As ideal triage does not yet exist, optimal strategy based on current knowledge should be obtained. aim this article present overview available options women, their strengths and limitations possible future opportunities.Areas covered: Current morphological biomarkers, molecular biomarkers strategies will discussed give the state-of-the-art women. literature search was studies women.Expert commentary: Experience morphology-based mak...

参考文章(127)
Harald zur Hausen, Human papillomaviruses and their possible role in squamous cell carcinomas. Current Topics in Microbiology and Immunology. ,vol. 78, pp. 1- 30 ,(1977) , 10.1007/978-3-642-66800-5_1
G N Papanicolaou, H F Traut, The diagnostic value of vaginal smears in carcinoma of the uterus. 1941. Archives of Pathology & Laboratory Medicine. ,vol. 121, pp. 211- 224 ,(1997)
Adam R. Brentnall, Natasa Vasiljevic, Dorota Scibior-Bentkowska, Louise Cadman, Janet Austin, Jack Cuzick, Attila T. Lorincz, HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier. Criminal Behaviour and Mental Health. ,vol. 15, pp. 669- 675 ,(2015) , 10.3233/CBM-150507
Remko P. Bosgraaf, Viola M.J. Verhoef, Leon F.A.G. Massuger, Albert G. Siebers, Johan Bulten, Gabriëlle M. de Kuyper-de Ridder, Chris J.M. Meijer, Peter J.F. Snijders, Daniëlle A.M. Heideman, Joanna IntHout, Folkert J. van Kemenade, Willem J.G. Melchers, Ruud L.M. Bekkers, Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening International Journal of Cancer. ,vol. 136, pp. 646- 655 ,(2014) , 10.1002/IJC.29026
Mariska Bierkens, Albertus T. Hesselink, Chris J.L.M. Meijer, Daniëlle A.M. Heideman, G. Bea A. Wisman, Ate G.J. van der Zee, Peter J.F. Snijders, Renske D.M. Steenbergen, CADM1 and MAL promoter methylation levels in hrHPV‐positive cervical scrapes increase proportional to degree and duration of underlying cervical disease International Journal of Cancer. ,vol. 133, pp. 1293- 1299 ,(2013) , 10.1002/IJC.28138
John Doorbar, Nagayasu Egawa, Heather Griffin, Christian Kranjec, Isao Murakami, Human papillomavirus molecular biology and disease association Reviews in Medical Virology. ,vol. 25, pp. 2- 23 ,(2015) , 10.1002/RMV.1822
Christine Bergeron, Guglielmo Ronco, Miriam Reuschenbach, Nicolas Wentzensen, Marc Arbyn, Mark Stoler, Magnus Knebel Doeberitz, The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: An update of recent developments International Journal of Cancer. ,vol. 136, pp. 2741- 2751 ,(2015) , 10.1002/IJC.28900
Romy van Baars, Jacolien van der Marel, Peter J.F. Snijders, Agata Rodriquez-Manfredi, Bram ter Harmsel, Henk A.M. van den Munckhof, Jaume Ordi, Marta del Pino, Miekel M. van de Sandt, N. Wentzensen, Chris J.L.M. Meijer, Wim G.V. Quint, CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies. International Journal of Cancer. ,vol. 138, pp. 463- 471 ,(2016) , 10.1002/IJC.29706
Dietmar Schmidt, Christine Bergeron, Karin J Denton, Ruediger Ridder, , p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology Cancer Cytopathology. ,vol. 119, pp. 158- 166 ,(2011) , 10.1002/CNCY.20140
Junichi Sakane, Kiyomi Taniyama, Kazuaki Miyamoto, Akihisa Saito, Kazuya Kuraoka, Toshinao Nishimura, Kazuhiro Sentani, Naohide Oue, Wataru Yasui, Aberrant DNA methylation of DLX4 and SIM1 is a predictive marker for disease progression of uterine cervical low-grade squamous intraepithelial lesion. Diagnostic Cytopathology. ,vol. 43, pp. 462- 470 ,(2015) , 10.1002/DC.23256